What is Galactosemia?

Galactosemia is a rare genetic disorder that causes an inability to digest galactose, which is a breakdown product of lactose.

Lactose is one of the main carbohydrates in milk. In the infant intestine, this lactose is broken down into glucose and galactose, which are then used as a source of energy. The galactose is further converted to glucose via a series of enzymatic reactions.

One of the enzymes involved is galactose-1-phosphate uridyl transferase (GALT) and in galactosemia, this enzyme is either defective or missing. When this happens, an infant is unable to convert the galactose into glucose which causes galactose to accumulate in the blood. This can lead to serious problems such as liver enlargement, kidney failure, brain damage and cataracts. Left untreated, this condition kills as many as 75% of sufferers.

As milk is the staple diet for babies, the condition needs to be diagnosed as soon as possible to improve the chance of survival.

Galactosemia affects around 1 in every 60,000 infants of European origin. The condition is caused by a mutation in the gene that codes for the GALT enzyme.

Galactosemia is inherited in an autosomal recessive manner, which means a child only develops the condition if they inherit an abnormal copy of the GALT gene from each of their parents.

Therefore, each child born to carrier parents has a 50% chance of being born a carrier of the condition, a 25% chance of developing the condition and a 25% chance of neither developing or carrying the condition.

Clinical features

Most babies born with galactosemia do not present with symptoms initially but jaundice, diarrhea and vomiting soon develop. The baby fails to thrive and may lose weight.

If the condition is not detected and treated early, infants eventually develop serious conditions such as liver disease, brain damage and are even at risk of dying.

Diagnosis and treatment

Prenatal tests can be performed to check for galactosemia as early on as in the 15th to 16th week of pregnancy. The condition is usually first detected through a heel prick test performed 72 hours after birth as part of newborn screening.

The condition is managed by feeding infants on a diet that is lactose and galactose free. This helps to prevent complications such as liver and kidney damage, although some individuals still go on to develop long-term complications.

Further Reading

Last Updated: Jun 16, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, June 16). What is Galactosemia?. News-Medical. Retrieved on June 22, 2024 from https://www.news-medical.net/health/What-is-Galactosemia.aspx.

  • MLA

    Mandal, Ananya. "What is Galactosemia?". News-Medical. 22 June 2024. <https://www.news-medical.net/health/What-is-Galactosemia.aspx>.

  • Chicago

    Mandal, Ananya. "What is Galactosemia?". News-Medical. https://www.news-medical.net/health/What-is-Galactosemia.aspx. (accessed June 22, 2024).

  • Harvard

    Mandal, Ananya. 2023. What is Galactosemia?. News-Medical, viewed 22 June 2024, https://www.news-medical.net/health/What-is-Galactosemia.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.